Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate minocycline as a potential treatment for bipolar depression when added to a mood-stabilizing medication. Minocycline is an antibiotic that is approved for the ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Icahn School of Medicine at Mount Sinai
NCT07172516 · Bipolar Disorder, Bipolar Depression, and more
NCT06370988 · Bipolar Depression, Bipolar Disorder, and more
NCT04480918 · Treatment Resistant Depression, Major Depressive Episode, and more
NCT06524505 · Bipolar Depression
NCT06599099 · Bipolar Depression
Icahn School of Medicine at Mount Sinai
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions